Compile Data Set for Download or QSAR
Report error Found 58 Enz. Inhib. hit(s) with all data for entry = 50003048
TargetActivin receptor type-1(Mouse)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466190(CHEMBL4288921)
Affinity DataEC50:  91nMAssay Description:Inhibition of BMP6-induced ALK2 transcriptional activity in mouse C2C12 cells expressing BRE-Luc after 30 mins by luciferase reporter gene assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Mouse)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataEC50:  8nMAssay Description:Inhibition of BMP6-induced ALK2 transcriptional activity in mouse C2C12 cells expressing BRE-Luc after 30 mins by luciferase reporter gene assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Mouse)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50262079(LDN-193189 | 4-[6-(4-piperazin-1-ylphenyl)pyrazolo...)
Affinity DataEC50:  14nMAssay Description:Inhibition of BMP6-induced ALK2 transcriptional activity in mouse C2C12 cells expressing BRE-Luc after 30 mins by luciferase reporter gene assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM111123(US9682983, 2 | US10017516, Compound 2)
Affinity DataIC50: 7nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 9nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM111123(US9682983, 2 | US10017516, Compound 2)
Affinity DataIC50: 9nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466195(CHEMBL4278763)
Affinity DataIC50: 16nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50262079(LDN-193189 | 4-[6-(4-piperazin-1-ylphenyl)pyrazolo...)
Affinity DataIC50: 17nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50262079(LDN-193189 | 4-[6-(4-piperazin-1-ylphenyl)pyrazolo...)
Affinity DataIC50: 19nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466190(CHEMBL4288921)
Affinity DataIC50: 19nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466182(CHEMBL4293917)
Affinity DataIC50: 25nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466198(CHEMBL4281166)
Affinity DataIC50: 27nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466186(CHEMBL4283315)
Affinity DataIC50: 29nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466200(CHEMBL4278219)
Affinity DataIC50: 47nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466187(CHEMBL4288905)
Affinity DataIC50: 48nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase receptor R3(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 51nMAssay Description:Inhibition of ALK1 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466201(CHEMBL4283587)
Affinity DataIC50: 54nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466194(CHEMBL4285523)
Affinity DataIC50: 63nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466193(CHEMBL4277239)
Affinity DataIC50: 93nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466196(CHEMBL4281706)
Affinity DataIC50: 109nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466181(CHEMBL4285138)
Affinity DataIC50: 246nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466184(CHEMBL4292331)
Affinity DataIC50: 291nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466191(CHEMBL4278242)
Affinity DataIC50: 326nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466192(CHEMBL4280585)
Affinity DataIC50: 422nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466201(CHEMBL4283587)
Affinity DataIC50: 444nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466189(CHEMBL4277180)
Affinity DataIC50: 526nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetTGF-beta receptor type-2(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 698nMAssay Description:Inhibition of recombinant N-terminal GST-tagged human TGFbetaR2 expressed in Baculovirus expression system by LanthaScreen assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466180(CHEMBL4290804)
Affinity DataIC50: 738nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466197(CHEMBL4291950)
Affinity DataIC50: 796nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466185(CHEMBL4279135)
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466188(CHEMBL4288494)
Affinity DataIC50: 1.97E+3nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-2A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 2.37E+3nMAssay Description:Inhibition of full length GST-tagged human ACVR2A expressed in Baculovirus expression system by LanthaScreen assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466196(CHEMBL4281706)
Affinity DataIC50: 2.53E+3nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-2B(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 3.13E+3nMAssay Description:Inhibition of GST-tagged human ACVR2B catalytic domain (185 to 488 residues) expressed in Baculovirus expression system by LanthaScreen assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466190(CHEMBL4288921)
Affinity DataIC50: 3.47E+3nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetActivin receptor type-1(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466199(CHEMBL4291891)
Affinity DataIC50: 5.99E+3nMAssay Description:Inhibition of ALK2 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 6.44E+3nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466195(CHEMBL4278763)
Affinity DataIC50: 8.20E+3nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466197(CHEMBL4291950)
Affinity DataIC50: 8.90E+3nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466186(CHEMBL4283315)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466180(CHEMBL4290804)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466191(CHEMBL4278242)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466200(CHEMBL4278219)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466194(CHEMBL4285523)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466188(CHEMBL4288494)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-2(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466183(CHEMBL4283638)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant His-tagged human BMPR2 (174 to end residues) by LanthaScreen assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466198(CHEMBL4281166)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466193(CHEMBL4277239)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466185(CHEMBL4279135)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetBone morphogenetic protein receptor type-1A(Human)
National Center For Advancing Translational Sciences

Curated by ChEMBL
LigandPNGBDBM50466192(CHEMBL4280585)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK3 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: